Atlas Trials

An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus

Clinical trial NCT06730672 · RECRUITING

Trial details

NCT number
NCT06730672
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma Stage I
Start date
2024-12-30
Primary completion
2027-12-27
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.